Acurx Pharmaceuticals (ACXP) Stock Chart & Stock Price History → Americans Now Need $1.46M to Retire… (From Crypto 101 Media) (Ad) Free ACXP Stock Alerts $2.16 -0.09 (-4.00%) (As of 05/16/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Acurx Pharmaceuticals Stock Price Performance5 Day Performance+6.40%1 Month Performance+30.12%3 Month Performance-32.92%6 Month Performance-40.33%Year-To-Date Performance-43.60%1 Year Performance-31.21% Receive ACXP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. ACXP Stock Chart for Thursday, May, 16, 2024 ACXP Chart by TradingView Acurx Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/16/2024$2.25$2.16-4.00%$2.33$2.1552,965 shs$34.04 million05/15/2024$2.09$2.25+7.66%$2.36$2.14170,421 shs$35.46 million05/14/2024$2.09$2.09$2.12$2.0254,337 shs$32.94 million05/13/2024$2.03$2.09+2.96%$2.11$2.0311,699 shs$32.94 million05/10/2024$2.02$2.03+0.50%$2.06$1.9916,796 shs$31.99 million05/09/2024$1.94$2.02+4.12%$2.04$1.8575,052 shs$31.84 million Get the Latest News and Ratings for ACXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/08/2024$1.97$1.94-1.52%$2.03$1.9020,197 shs$30.57 million05/07/2024$2.08$1.97-5.29%$2.09$1.9726,226 shs$31.05 million05/06/2024$2.17$2.08-4.15%$2.24$2.0441,098 shs$32.78 million05/03/2024$2.12$2.17+2.36%$2.21$2.1032,524 shs$34.20 million05/02/2024$2.16$2.12-1.85%$2.22$2.0625,534 shs$33.41 million05/01/2024$2.25$2.16-4.00%$2.32$2.1378,610 shs$34.67 million04/30/2024$2.19$2.25+2.74%$2.30$2.1034,435 shs$35.46 million04/29/2024$2.07$2.19+5.80%$2.33$2.0285,884 shs$34.51 million04/26/2024$2.02$2.07+2.48%$2.08$1.9828,594 shs$32.62 million04/25/2024$2.03$2.02-0.49%$2.13$1.9685,169 shs$31.84 million04/24/2024$2.04$2.03-0.49%$2.07$1.9716,633 shs$31.99 million04/23/2024$1.98$2.04+3.03%$2.05$1.9429,691 shs$32.15 million04/22/2024$2.01$1.98-1.49%$2.01$1.9051,986 shs$31.20 million04/19/2024$2.13$2.01-5.63%$2.17$1.9793,506 shs$31.68 million04/18/2024$1.80$2.13+18.33%$2.13$1.80141,555 shs$33.57 million04/17/2024$1.66$1.80+8.43%$1.84$1.62114,332 shs$28.37 million04/16/2024$1.64$1.66+1.53%$1.79$1.52247,497 shs$26.16 million04/15/2024$1.77$1.64-7.63%$1.82$1.6292,843 shs$25.77 million04/12/2024$1.87$1.77-5.35%$1.86$1.66172,233 shs$27.90 million04/11/2024$1.86$1.87+0.54%$1.91$1.8425,415 shs$29.47 million04/10/2024$1.93$1.86-3.63%$1.96$1.80106,244 shs$29.31 million04/09/2024$1.91$1.93+1.05%$1.95$1.8924,775 shs$30.42 million04/08/2024$1.93$1.91-1.04%$1.99$1.8877,001 shs$30.10 million04/05/2024$1.96$1.93-1.53%$1.95$1.8963,173 shs$30.42 million04/04/2024$2.00$1.96-2.00%$2.07$1.9453,847 shs$30.89 million04/03/2024$2.17$2.00-7.83%$2.19$1.98100,587 shs$31.52 million04/02/2024$2.28$2.17-4.82%$2.28$2.1465,977 shs$34.20 million04/01/2024$2.45$2.28-6.94%$2.43$2.2326,583 shs$35.93 million03/29/2024$2.45$2.45$2.48$2.3684,623 shs$38.61 million03/28/2024$2.33$2.45+5.15%$2.48$2.3684,600 shs$38.61 million03/27/2024$2.08$2.33+12.02%$2.44$2.0586,698 shs$36.72 million03/26/2024$2.09$2.08-0.48%$2.10$2.0260,098 shs$32.78 million03/25/2024$1.94$2.09+7.73%$2.14$1.93112,909 shs$32.94 million03/22/2024$2.06$1.94-5.83%$2.05$1.9283,988 shs$30.57 millionA ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x!Just click here to learn how you can access this coin right now.03/21/2024$2.11$2.06-2.37%$2.16$1.84168,096 shs$32.47 million03/20/2024$2.11$2.11$2.20$1.98119,991 shs$33.25 million03/19/2024$2.59$2.11-18.53%$2.39$2.11304,901 shs$29.05 million03/18/2024$2.72$2.59-4.78%$2.92$2.59172,235 shs$35.66 million03/15/2024$2.71$2.72+0.37%$2.92$2.70118,098 shs$37.45 million03/14/2024$2.80$2.71-3.21%$2.88$2.7043,056 shs$37.31 million03/13/2024$2.86$2.80-2.10%$2.90$2.8020,479 shs$38.56 million03/12/2024$2.84$2.86+0.70%$2.94$2.8122,570 shs$39.38 million03/11/2024$2.91$2.84-2.41%$2.98$2.8222,411 shs$39.11 million03/08/2024$2.97$2.91-2.02%$3.06$2.8223,377 shs$40.07 million03/07/2024$3.00$2.97-1.00%$3.02$2.9035,891 shs$40.90 million03/06/2024$2.99$3.00+0.33%$3.02$2.8044,510 shs$41.31 million03/05/2024$2.93$2.99+2.05%$3.05$2.8353,933 shs$41.17 million03/04/2024$2.96$2.93-1.01%$2.98$2.8336,782 shs$40.35 million03/01/2024$2.87$2.96+3.14%$3.17$2.8262,772 shs$40.76 million02/29/2024$2.92$2.87-1.71%$3.01$2.8066,923 shs$39.51 million02/28/2024$3.13$2.92-6.71%$3.18$2.8696,056 shs$40.21 million02/27/2024$3.25$3.13-3.69%$3.35$3.00180,520 shs$43.10 million02/26/2024$3.15$3.25+3.17%$3.29$3.0171,802 shs$44.75 million02/23/2024$3.13$3.15+0.64%$3.17$3.0257,174 shs$43.38 million02/22/2024$2.95$3.13+6.10%$3.19$2.9461,766 shs$43.10 million02/21/2024$2.92$2.95+1.03%$3.07$2.8587,487 shs$40.62 million02/20/2024$3.23$2.92-9.60%$3.26$2.8665,339 shs$40.21 million02/19/2024$3.23$3.23+0.16%$3.28$2.90315,200 shs$44.47 million02/16/2024$3.05$3.22+5.57%$3.28$2.90314,158 shs$44.34 million02/15/2024$2.99$3.05+2.01%$3.06$2.8756,102 shs$41.99 million Related Companies: NRx Pharmaceuticals Stock Price Chart BriaCell Therapeutics Stock Price Chart Fortress Biotech Stock Price Chart Aprea Therapeutics Stock Price Chart Spruce Biosciences Stock Price Chart Apollomics Stock Price Chart Daré Bioscience Stock Price Chart ImmunoPrecise Antibodies Stock Price Chart Viracta Therapeutics Stock Price Chart Theratechnologies Stock Price Chart Receive ACXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACXP) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsThe 1,000X Crypto PlaybookTrue Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityThe #1 Crypto for AIWeiss RatingsWhy Is Gold On a MASSIVE rally? Huge AlertsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acurx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.